Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.55
+1.54 (19.23%)
At close: Mar 9, 2026, 4:00 PM EDT
9.50
-0.05 (-0.52%)
After-hours: Mar 9, 2026, 7:54 PM EDT
CRBP Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | - | -40.21 | -44.6 | -42.35 | -45.64 | |
| Depreciation & Amortization | - | 0.59 | 0.64 | 0.76 | 1.64 | |
| Other Amortization | - | 0.4 | 0.82 | 0.74 | 0.7 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.02 | 0.1 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.61 | |
| Loss (Gain) From Sale of Investments | - | -3.33 | -0.51 | 0.3 | 0.7 | |
| Stock-Based Compensation | - | 6.15 | 3.47 | 5.72 | 9.73 | |
| Other Operating Activities | - | 0.19 | -0.02 | 0.55 | -0.32 | |
| Change in Accounts Receivable | - | - | - | - | 1.62 | |
| Change in Accounts Payable | - | 1.6 | 1.03 | -0.26 | -5.96 | |
| Change in Other Net Operating Assets | - | -7.18 | 3.07 | -3.04 | -11.36 | |
| Operating Cash Flow | - | -41.79 | -36.1 | -37.54 | -48.18 | |
| Capital Expenditures | - | - | - | -0.01 | -0.05 | |
| Sale of Property, Plant & Equipment | - | - | - | 0.01 | 0.02 | |
| Investment in Securities | - | -121.31 | 35.64 | 30.08 | -73.39 | |
| Investing Cash Flow | - | -121.31 | 35.64 | 30.07 | -73.42 | |
| Short-Term Debt Issued | - | - | 0.37 | 0.45 | 0.98 | |
| Long-Term Debt Issued | - | - | - | 1.38 | - | |
| Total Debt Issued | - | - | 0.37 | 1.83 | 0.98 | |
| Short-Term Debt Repaid | - | -0.3 | -0.43 | -0.87 | -0.93 | |
| Long-Term Debt Repaid | - | -15.18 | -2.82 | -1.5 | - | |
| Total Debt Repaid | - | -15.48 | -3.25 | -2.37 | -0.93 | |
| Net Debt Issued (Repaid) | - | -15.48 | -2.87 | -0.53 | 0.06 | |
| Issuance of Common Stock | - | 182.06 | 0.05 | - | 62.59 | |
| Other Financing Activities | - | - | - | - | -1.82 | |
| Financing Cash Flow | - | 166.58 | -2.82 | -0.53 | 60.82 | |
| Net Cash Flow | - | 3.47 | -3.28 | -8 | -60.78 | |
| Free Cash Flow | - | -41.79 | -36.1 | -37.56 | -48.24 | |
| Free Cash Flow Margin | - | - | - | - | -5470.98% | |
| Free Cash Flow Per Share | - | -3.83 | -8.34 | -9.01 | -11.78 | |
| Cash Interest Paid | - | 2.82 | 2.61 | 1.97 | 1.74 | |
| Levered Free Cash Flow | - | -29.8 | -21.27 | -18.72 | -39.01 | |
| Unlevered Free Cash Flow | - | -29.03 | -19.68 | -17.53 | -38.02 | |
| Change in Working Capital | - | -5.58 | 4.09 | -3.3 | -15.7 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.